Technical Analysis for STXS - Stereotaxis, Inc.

Grade Last Price % Change Price Change
C 2.48 0.00% 0.00
STXS closed unchanged on Monday, March 18, 2024, on 87 percent of normal volume.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down

Date Alert Name Type % Chg
MACD Bearish Centerline Cross Bearish 0.00%
Wide Bands Range Expansion 0.00%
Gapped Down Weakness 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
NR7 Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Spinning Top Other 1.22%
Stochastic Reached Oversold Weakness 1.22%
Wide Bands Range Expansion 1.22%

   Recent Intraday Alerts

Alert Time
Up 3% about 7 hours ago
Up 2% about 10 hours ago
60 Minute Opening Range Breakout about 11 hours ago
Rose Above 10 DMA about 11 hours ago
Gap Down Partially Closed about 12 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Stereotaxis, Inc. Description

Stereotaxis, Inc. designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Its products include Niobe ES robotic magnetic navigation system that enables physicians to complete interventional procedures by providing image guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures. The company also offers Odyssey solution, a real-time information solution to manage, control, record, and share procedures across networks. In addition, it provides disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company's disposables and other accessories include V-CAS and V-CAS Deflect catheter advancement systems; and V-loop circular and V-Sono ICE catheter manipulators. The company markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was founded in 1990 and is headquartered in St. Louis, Missouri.


Classification

Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Medicine Biotechnology Catheter Ablation Cardiac Electrophysiology Physiology Electrophysiology Robotic Systems Therapeutic Device Computer Assisted Surgery Stereotaxis

Is STXS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 3.29
52 Week Low 1.33
Average Volume 280,360
200-Day Moving Average 1.83
50-Day Moving Average 2.38
20-Day Moving Average 2.70
10-Day Moving Average 2.51
Average True Range 0.18
RSI (14) 47.09
ADX 25.23
+DI 24.58
-DI 21.40
Chandelier Exit (Long, 3 ATRs) 2.74
Chandelier Exit (Short, 3 ATRs) 2.86
Upper Bollinger Bands 3.16
Lower Bollinger Band 2.24
Percent B (%b) 0.26
BandWidth 34.20
MACD Line 0.00
MACD Signal Line 0.05
MACD Histogram -0.0514
Fundamentals Value
Market Cap 200.59 Million
Num Shares 80.9 Million
EPS -0.27
Price-to-Earnings (P/E) Ratio -9.19
Price-to-Sales 7.10
Price-to-Book 11.19
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.70
Resistance 3 (R3) 2.70 2.63 2.66
Resistance 2 (R2) 2.63 2.57 2.63 2.65
Resistance 1 (R1) 2.56 2.54 2.59 2.55 2.64
Pivot Point 2.49 2.49 2.50 2.48 2.49
Support 1 (S1) 2.41 2.43 2.45 2.41 2.32
Support 2 (S2) 2.34 2.40 2.34 2.31
Support 3 (S3) 2.27 2.34 2.30
Support 4 (S4) 2.26